---
title: "Dimethyl Fumarate - Psoriasis"
sidebar: mydoc_sidebar
permalink: db08908-mesh-d011565-1.html
toc: false 
---


Path ID: `DB08908_MESH_D011565_1`
{% include image.html url="images/db08908-mesh-d011565-1.png" file="db08908-mesh-d011565-1.png" alt="db08908-mesh-d011565-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/DB:DB08908">DB:DB08908 </a> | Dimethyl fumarate | Drug |
| <a href="https://identifiers.org/GO:0038061">GO:0038061 </a> | NIK/NF-kappaB signaling | BiologicalProcess |
| <a href="https://identifiers.org/GO:0001816">GO:0001816 </a> | Cytokine production | BiologicalProcess |
| <a href="https://identifiers.org/GO:0006954">GO:0006954 </a> | Inflammatory response | BiologicalProcess |
| <a href="https://identifiers.org/reactome:R-HSA-8932339">reactome:R-HSA-8932339 </a> | ROS sensing by NFE2L2 | Pathway |
| <a href="https://identifiers.org/UniProt:P09601">UniProt:P09601 </a> | Heme oxygenase 1 | Protein |
| <a href="https://identifiers.org/UniProt:Q8TDS4">UniProt:Q8TDS4 </a> | Hydroxycarboxylic acid receptor 2 | Protein |
| <a href="https://identifiers.org/GO:1990266">GO:1990266 </a> | Neutrophil migration | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D011565">MESH:D011565 </a> | Psoriasis | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Dimethyl Fumarate | NEGATIVELY REGULATES | Nik/Nf-Kappab Signaling |
| Nik/Nf-Kappab Signaling | POSITIVELY REGULATES | Cytokine Production |
| Cytokine Production | POSITIVELY CORRELATED WITH | Inflammatory Response |
| Dimethyl Fumarate | POSITIVELY REGULATES | Ros Sensing By Nfe2L2 |
| Ros Sensing By Nfe2L2 | INCREASES ACTIVITY OF | Heme Oxygenase 1 |
| Heme Oxygenase 1 | NEGATIVELY REGULATES | Inflammatory Response |
| Dimethyl Fumarate | INCREASES ACTIVITY OF | Hydroxycarboxylic Acid Receptor 2 |
| Hydroxycarboxylic Acid Receptor 2 | NEGATIVELY REGULATES | Neutrophil Migration |
| Neutrophil Migration | POSITIVELY CORRELATED WITH | Inflammatory Response |
| Inflammatory Response | CAUSES | Psoriasis |
|---------|-----------|---------|

Comment: Fumaric acid is used for the treatment of psoriasis in an ester form as dimethyl fumarate. This graph was made for dimethyl fumarate. Dimethyl fumarate ia a prodrug which is metabolised into the pharmacologically active monomethyl fumarate.

Reference: 
  - [https://pubmed.ncbi.nlm.nih.gov/27271164/](https://pubmed.ncbi.nlm.nih.gov/27271164/)
  - [https://onlinelibrary.wiley.com/doi/10.1111/exd.13548](https://onlinelibrary.wiley.com/doi/10.1111/exd.13548)
  - [https://go.drugbank.com/drugs/DB08908](https://go.drugbank.com/drugs/DB08908)
